|
⚲
|
| Cardax Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001408223 |
| Sale | 2008-12-09 ($4.8 M Offered, $0.6 M Sold) |
| Fund | |
| Phone | 8084571375 |
| Address | 99193 Aiea Hights Drive Aiea, 96701 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Nicholas Mitsakos | |
| Thomas Goodin | |
| Fredric Pashkow | |
| Frank Herringer | |
| David Watumull |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
KRE MREG Main Line Venture REIT LLC
✚
|
0.0 | |
|
Krepiakevich Terry
✚
|
0.0 | |
|
KRE Quincy REIT Manager LLC
✚
|
0.0 | |
|
Swing Therapeutics, Inc.
✚
|
0.0 | |
|
Swordfish Holdings LLC
✚
|
0.0 | |
|
Swytchboard, Inc.
✚
|
0.0 | |
|
KRE Southline REIT Holdings LLC
✚
|
0.0 | |
|
Krevolin Bret H
✚
|
0.0 | |
|
Krieger Bernd R.
✚
|
0.0 | |
|
Qunnect, LLC
✚
|
0.0 |